In a new study, second-line ruxolitinib was associated with marked regression of splenomegaly and with cytopenias in patients ...

Patients with cardiac amyloidosis and AF showed no meaningful difference in thromboembolic or bleeding outcomes when treated ...

A new clinical development program, PALM, is testing TPIP in 4 clinical trials in patients with IPF and other conditions.

Moderate-to-severe bone marrow fibrosis was associated with inferior overall survival, particularly in patients with ...

Intensive chemotherapy and allogeneic hematopoietic cell transplantation put t(8;21) acute myeloid leukemia (AML) into ...

A new clinical development program, PALM, is testing TPIP in 3 active clinical trials in patients with PAH and other ...

Clinicians initially suspected SM in a man with a blast-phase PDGFRA neoplasm with basophilia, spindle-shaped mast cells, and ...

A 12-week modified yoga program appeared to be associated with improvements in selected patient-reported outcome domains ...

Zanubrutinib was associated with significantly better overall survival than ibrutinib or acalabrutinib among veterans with ...

A mother relives the nightmare of her son’s FCS-related death when her daughter, who also has FCS, is hospitalized with acute ...

Combined immunoadsorption, high-dose IVIG, and rituximab may help manage pregnancies at high risk for severe HDFN, per a ...

Removing biopsy requirements from ATTR-CM diagnostic and treatment guidelines could minimize invasive procedures for patients ...